XTNT Xtant Medical Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: XTNT

Price (delayed)

$0.85

Market cap

$110.68M

P/E Ratio

85

Dividend/share

N/A

EPS

$0.01

Enterprise value

$128.32M

Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal ...

Highlights
The company's EPS has surged by 111% YoY
The company's gross profit has surged by 73% YoY and by 19% QoQ
XTNT's net income has soared by 108% year-on-year but it has dropped by 76% since the previous quarter
The equity has soared by 50% YoY but it has contracted by 6% from the previous quarter
Xtant Medical Holdings's quick ratio has decreased by 44% YoY and by 9% from the previous quarter
XTNT's debt is up by 38% year-on-year and by 2.3% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://xtantmedical.com
Peers: STE SYK

Key stats

What are the main financial stats of XTNT
Market
Shares outstanding
130.22M
Market cap
$110.68M
Enterprise value
$128.32M
Valuations
Price to earnings (P/E)
85
Price to book (P/B)
2.15
Price to sales (P/S)
1.11
EV/EBIT
67.5
EV/EBITDA
25.28
EV/Sales
1.41
Earnings
Revenue
$91.3M
EBIT
$1.9M
EBITDA
$5.08M
Free cash flow
-$10.8M
Per share
EPS
$0.01
Free cash flow per share
-$0.09
Book value per share
$0.39
Revenue per share
$0.77
TBVPS
$0.63
Balance sheet
Total assets
$92.61M
Total liabilities
$41.26M
Debt
$23.56M
Equity
$51.35M
Working capital
$41.88M
Liquidity
Debt to equity
0.46
Current ratio
2.82
Quick ratio
1.16
Net debt/EBITDA
3.48
Margins
EBITDA margin
5.6%
Gross margin
60.8%
Net margin
0.7%
Operating margin
-11.1%
Efficiency
Return on assets
0.8%
Return on equity
1.6%
Return on invested capital
3.3%
Return on capital employed
2.7%
Return on sales
2.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XTNT stock price

How has the Xtant Medical Holdings stock price performed over time
Intraday
-1.16%
1 week
-10.53%
1 month
-13.53%
1 year
41.62%
YTD
-24.78%
QTD
-27.35%

Financial performance

How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$91.3M
Gross profit
$55.47M
Operating income
-$10.16M
Net income
$660,000
Gross margin
60.8%
Net margin
0.7%
XTNT's net income has soared by 108% year-on-year but it has dropped by 76% since the previous quarter
XTNT's net margin has surged by 105% year-on-year but it has dropped by 80% since the previous quarter
The company's gross profit has surged by 73% YoY and by 19% QoQ
The revenue has soared by 58% year-on-year and by 16% since the previous quarter

Growth

What is Xtant Medical Holdings's growth rate over time

Valuation

What is Xtant Medical Holdings stock price valuation
P/E
85
P/B
2.15
P/S
1.11
EV/EBIT
67.5
EV/EBITDA
25.28
EV/Sales
1.41
The company's EPS has surged by 111% YoY
The equity has soared by 50% YoY but it has contracted by 6% from the previous quarter
XTNT's P/B is 20% below its last 4 quarters average of 2.7
The revenue has soared by 58% year-on-year and by 16% since the previous quarter
The stock's price to sales (P/S) is 26% less than its last 4 quarters average of 1.5

Efficiency

How efficient is Xtant Medical Holdings business performance
Xtant Medical Holdings's ROIC has soared by 119% YoY but it has decreased by 48% from the previous quarter
The company's return on sales has surged by 118% YoY but it fell by 48% QoQ
The ROE has soared by 106% YoY but it has plunged by 78% from the previous quarter
Xtant Medical Holdings's ROA has soared by 105% YoY but it has plunged by 79% from the previous quarter

Dividends

What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XTNT.

Financial health

How did Xtant Medical Holdings financials performed over time
The total assets is 124% more than the total liabilities
Xtant Medical Holdings's total liabilities has soared by 58% YoY and by 11% from the previous quarter
The total assets has soared by 54% YoY
XTNT's debt is 54% smaller than its equity
The equity has soared by 50% YoY but it has contracted by 6% from the previous quarter
XTNT's debt is up by 38% year-on-year and by 2.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.